New York State Common Retirement Fund
STRO icon

New York State Common Retirement Fund’s Sutro Biopharma STRO Stock Holding History

New York State Common Retirement Fund’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Buy
+5,600
New +$175K ﹤0.01% 2400
2025
Q2 		– Sell
-1,363
Closed -$8.86K – 3333
2025
Q1 		$8.86K Hold
1,363
– – ﹤0.01% 3089
2024
Q4 		$25.1K Hold
1,363
– – ﹤0.01% 3003
2024
Q3 		$47.1K Hold
1,363
– – ﹤0.01% 2882
2024
Q2 		$39.9K Buy
1,363
+21
+2% +$830 ﹤0.01% 3136
2024
Q1 		$75.8K Sell
1,342
-22
-2% -$972 ﹤0.01% 2843
2023
Q4 		$58.5K Sell
1,364
-12
-0.9% -$381 ﹤0.01% 2948
2023
Q3 		$47.7K Buy
1,376
+26
+2% +$1.13K ﹤0.01% 3035
2023
Q2 		$62.8K Sell
1,350
-7
-0.5% -$348 ﹤0.01% 3085
2023
Q1 		$62.7K Sell
1,357
-1,782
-57% -$113K ﹤0.01% 2934
2022
Q4 		$254K Buy
3,139
+1,227
+64% +$85.3K ﹤0.01% 2626
2022
Q3 		$106K Buy
1,912
+10
+0.5% +$592 ﹤0.01% 2997
2022
Q2 		$99K Sell
1,902
-1,226
-39% -$68.5K ﹤0.01% 3063
2022
Q1 		$257K Hold
3,128
– – ﹤0.01% 2722
2021
Q4 		$465K Sell
3,128
-7
-0.2% -$1.25K ﹤0.01% 2471
2021
Q3 		$592K Sell
3,135
-612
-16% -$116K ﹤0.01% 2368
2021
Q2 		$697K Buy
3,747
+1,397
+59% +$273K ﹤0.01% 2400
2021
Q1 		$535K Hold
2,350
– – ﹤0.01% 2416
2020
Q4 		$510K Buy
2,350
+1,250
+114% +$207K ﹤0.01% 2349
2020
Q3 		$111K Hold
1,100
– – ﹤0.01% 2881
2020
Q2 		$85K Hold
1,100
– – ﹤0.01% 3047
2020
Q1 		$112K Hold
1,100
– – ﹤0.01% 2720
2019
Q4 		$121K Hold
1,100
– – ﹤0.01% 2949
2019
Q3 		$100K Hold
1,100
– – ﹤0.01% 3029
2019
Q2 		$125K Buy
1,100
+990
+900% +$109K ﹤0.01% 3028
2019
Q1 		$13K Buy
+110
New +$11.4K ﹤0.01% 3144

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

New York State Common Retirement Fund's STRO Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Sutro Biopharma (STRO) in Q2 2026: 5,600 shares worth $186K. The stake represents ﹤0.01% of the portfolio and ranks #2400 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in STRO as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in STRO in Q1 2019 and has held it in 26 quarters since. The position peaked at $697K in Q2 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • New York State Common Retirement Fund held 5,600 shares of Sutro Biopharma worth $186K as of Q2 2026.
  • Sutro Biopharma was a new New York State Common Retirement Fund position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2400 holding.
  • New York State Common Retirement Fund first reported a position in Sutro Biopharma in Q1 2019 and has held it in 26 quarters since.
  • New York State Common Retirement Fund's Sutro Biopharma position peaked at $697K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.